Overview

Founded in June 2001, DxS offers pharmacogenomics services to support the discovery, development and marketing of pharmaceutical products. The company offers research genotyping to aid in the identification of lead candidates, clinical genotyping to aid in analyzing clinical trials and developing drugs, and diagnostic genotyping for drug marketing.

The company’s genotyping process is based on Scorpions Technology, a homogeneous or closed-tube method. A DNA sample is added to a Scorpions test and an increase in fluorescence indicates the genotype. There is no post-PCR manipulation and the use of two fluorescent dyes permits single-tube SNP analysis.